A detailed history of Hantz Financial Services, Inc. transactions in Natera, Inc. stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 54 shares of NTRA stock, worth $9,292. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54
Previous 1 5300.0%
Holding current value
$9,292
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 04, 2025

BUY
$132.23 - $171.87 $7,008 - $9,109
53 Added 5300.0%
54 $9,000
Q1 2025

May 12, 2025

BUY
$132.63 - $177.0 $132 - $177
1 New
1 $0
Q1 2024

Aug 06, 2024

BUY
$59.21 - $92.9 $592 - $929
10 New
10 $1,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.7B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.